Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factor

  • F. Blasi
  • R. Cosentini
  • P. Tarsia


In recent decades the understanding of lipid metabolism derangement (hypercholesterolaemia and decreased high-density lipoprotein cholesterol) together with tighter control of hypertension, diabetes and smoking habits have led to a substantial decrease in coronary heart disease (CHD) and stroke mortality [1]. Nonetheless, the above risk factors (together with age, gender and family history) are felt to account for approximately 50%–70% of the pathogenesis of cardiovascular diseases [2, 3]. Therefore, scientific attention has recently focused on investigating hypothetical additional risk factors and on a fuller understanding of the development of atherosclerosis, the main pathological process involved in CHD.


Atherosclerotic Plaque Acute Myocardial Infarction Abdominal Aorta Aneurysm Chlamydial Infection Coronary Heart Disease Patient 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Braunwald E (1997) Shattuck Lecture-Cardiovascular medicine at the turn of the millenium: triumphs, concerns, and opportunities. N Engl J Med 337: 1360–1369PubMedCrossRefGoogle Scholar
  2. 2.
    Solberg LA, Enger SC, Hjermann I et al (1980) Risk factors for coronary and cerebral atherosclerosis in the Oslo study. In: Giotto AM, Smith LC, Allen B (eds) Atherosclerosis. Springer, Berlin Heidelberg New York, pp 57–62Google Scholar
  3. 3.
    Beneditt EP, Gown AM (1980) Atheroma: the arterial wall and the environment. Int Rev Exp Pathol 21: 55–118Google Scholar
  4. 4.
    Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809PubMedCrossRefGoogle Scholar
  5. 5.
    Entman ML, Ballantyne CM (1993) Inflammation in acute coronary syndromes. Circulation 88: 800–803PubMedGoogle Scholar
  6. 6.
    Van derWal AC, Becker AE, van del Loos CM et al (1994) Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36–44PubMedGoogle Scholar
  7. 7.
    Tillett HE, Smith JW, Gooch CD (1983) Excess deaths attributed to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 12: 344–352PubMedCrossRefGoogle Scholar
  8. 8.
    Valtonen V, Kuikka A, Syrjanen J (1993) Thrombo-embolic complications in bacteriaemic infections. Eur Heart J 14: 20–23PubMedGoogle Scholar
  9. 9.
    Friedman HM (1989) Infection of endothelial cells by common human viruses. Rev Infect Dis 11: 5700–5704CrossRefGoogle Scholar
  10. 10.
    Osler W (1908) Diseases of the arteries. In: Osier W (ed) Modern medicine: its practice and theory. Lea & Febiger, Philadelphia, pp 429–447Google Scholar
  11. 11.
    Anitschkow N (1913) Über die Wandänderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beitr Pathol Anat Allg Pathol 56: 379–404Google Scholar
  12. 12.
    Frothingham C (1911) The relation between acute infectious diseases and arterial lesions. Arch Intern Med 8: 153–162CrossRefGoogle Scholar
  13. 13.
    Ophülus W (1921) Arteriosclerosis and cardiovascular disease: their relation to infectious diseases. JAMA 76: 700–701CrossRefGoogle Scholar
  14. 14.
    Fabricant CG, Fabricant J, Litrenta MM et al (1978) Virus-induced atherosclerosis. J Exp Med 148: 335–340PubMedCrossRefGoogle Scholar
  15. 15.
    Adam E, Melnick JL, Probstfield JL et al (1987) High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2: 291–293PubMedCrossRefGoogle Scholar
  16. 16.
    Petrie BL, Melnick JL, Adam E et al (1987) Nucleic acid sequence of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis 155: 158–159PubMedCrossRefGoogle Scholar
  17. 17.
    Hendricks MGR, Salimens MMM, Vauboven CPA et al (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136: 23–28Google Scholar
  18. 18.
    Gyorkey F, Melnick JL, Guinn GA et al (1984) Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerosis patients. Exp Mol Pathol 40: 328–339PubMedCrossRefGoogle Scholar
  19. 19.
    Span AHM, Grauls G, Bosman F et al (1992) Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 92: 41–52CrossRefGoogle Scholar
  20. 20.
    Yamashiroya HM, Ghosh L, Yang R et al (1988) Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 130: 71–79PubMedGoogle Scholar
  21. 21.
    Benditt EP, Barrett T, McDougall JK (1983) Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 80: 6386–6389PubMedCrossRefGoogle Scholar
  22. 22.
    Friedman HM, Macarak EJ, MacGregor RR et al (1981) Virus infection of endothelial cells. J Infect Dis 143: 266–273PubMedCrossRefGoogle Scholar
  23. 23.
    Minkowski WL (1947) The coronary arteries of infants. Am J Med Sci 214: 623–629PubMedCrossRefGoogle Scholar
  24. 24.
    Pesonen E, Siitonen O (1981) Acute myocardial infarction precipitated by infectious disease. Am Heart J 101: 512–513PubMedCrossRefGoogle Scholar
  25. 25.
    Mattila KJ, Valle MS, Nieminen MS et al (1993) Dental infections and coronary atherosclerosis. Atherosclerosis 103: 205–211PubMedCrossRefGoogle Scholar
  26. 26.
    Mendall M, Gogin P, Levy J et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71: 437–439PubMedCrossRefGoogle Scholar
  27. 27.
    Patel P, Mendall MA, Carrington D et al (1995) Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 31: 711–714CrossRefGoogle Scholar
  28. 28.
    Murray LJ, Bamford KB, O’Reilly DPJ et al (1995) Helicobacter pylori infection: relation with cardiovascular risk factors, ischemie heart disease, and social class. Br Heart J 74: 497–501PubMedCrossRefGoogle Scholar
  29. 29.
    Liuzzo G, Luigi M, Biasucci L et al (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417–424PubMedCrossRefGoogle Scholar
  30. 30.
    Yarnell JWG, Baker JA, Sweetman PM et al (1991) Fibrinogen, viscosity and white blood cell count are major risk factors for ischemie heart disease. Circulation 83: 836–844PubMedGoogle Scholar
  31. 31.
    Strandberg TE, Tilvis RS, Vuoristo M et al (1997) Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 314: 1317–1318PubMedCrossRefGoogle Scholar
  32. 32.
    Parente F, Maconi G, Imbesi V et al (1997) Helicobacter pylori infection and coagulation in healthy people. BMJ 314: 1318–1319PubMedCrossRefGoogle Scholar
  33. 33.
    Cunningham A, Ward M, Matthews R et al (1996) Helicobacter pylori and Chlamydia pneumoniae in tissues of myocardial infarction cases. 1st European Congress of Chemotherapy, Glasgow, abstract W149Google Scholar
  34. 34.
    Blasi F, Denti F, Erba M et al (1996) Detection of Chlamydia pneumoniae and not of Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34: 2766–2769PubMedGoogle Scholar
  35. 35.
    Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii: 983–986CrossRefGoogle Scholar
  36. 36.
    Leinonen M, Linnanmäki E, Mattila K et al (1990) Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 9: 67–73PubMedCrossRefGoogle Scholar
  37. 37.
    Saikku P, Leinonen M, Tenkanen L et al (1992) Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116: 273–278PubMedGoogle Scholar
  38. 38.
    Thom DH, Wang SP, Grayston JT et al (1991) Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 11: 547–551PubMedCrossRefGoogle Scholar
  39. 39.
    Thom DH, Grayston JT, Siscovick DS et al (1992) Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268: 68–72PubMedCrossRefGoogle Scholar
  40. 40.
    Linnanmäki E, Leinonen M, Mattila K et al (1993) Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary artery disease. Circulation 87: 1130–1134PubMedGoogle Scholar
  41. 41.
    Melnick SL, Sharar E, Folsom AR et al (1993) Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 95: 499–504PubMedCrossRefGoogle Scholar
  42. 42.
    Dahlen GH, Boman J, Birgander LS, Lindblom B (1995) Lp(a) lipoprotein, IgG, IgA, and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114: 165–174PubMedCrossRefGoogle Scholar
  43. 43.
    Mendall MA, Carrington D, Strachan D et al (1995) Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 30: 121–128PubMedCrossRefGoogle Scholar
  44. 44.
    Miettinen H, Lehto S, Saikku P et al (1996) Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetics and non-diabetic subjects in Finland. Eur Heart J 17: 682–688PubMedCrossRefGoogle Scholar
  45. 45.
    Carlsson J, Miketic S, Muller KH et al (1997) Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet 350: 1225 (letter)CrossRefGoogle Scholar
  46. 46.
    Laurila A, Bloigu A, Näyhä S et al (1997) Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. BMJ 314: 1456–1457PubMedCrossRefGoogle Scholar
  47. 47.
    Blasi F, Cosentini R, Raccanelli R et al (1997) A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 112: 309–312PubMedCrossRefGoogle Scholar
  48. 48.
    Cook PJ, Honeybourne D, Lip GYH et al (1998) Chlamydia pneumoniae antibody titres are significantly associated with acute stroke and transient cerebral ischemia. Stroke 29: 404–410PubMedCrossRefGoogle Scholar
  49. 49.
    Cook PJ, Lip GYH, Davies P et al (1998) Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 31: 589–594PubMedGoogle Scholar
  50. 50.
    Davidson M, Kuo C-C, Middaugh GP et al (1998) Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 98: 628–633PubMedGoogle Scholar
  51. 51.
    Wimmer MLJ, Sandmannstrupp R, Saikku P et al (1996) Association of chlamydial infection with cerebrovascular disease. Stroke 27: 2207–2210PubMedCrossRefGoogle Scholar
  52. 52.
    Toss H, Gnarpe J, Gnarpe H et al (1998) Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J 19: 570–577PubMedCrossRefGoogle Scholar
  53. 53.
    Anderson JL, Carlquist JF, Muhlestein JB et al (1998) Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 32: 35–41PubMedCrossRefGoogle Scholar
  54. 54.
    Weiss SM, Roblin PM, Gaydos CA et al (1996) Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173: 957–962PubMedCrossRefGoogle Scholar
  55. 55.
    Kark JD, Leinonen M, Paltiel O et al (1997) Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 26: 730–738PubMedCrossRefGoogle Scholar
  56. 56.
    Hahn DL, Golubjatnikov R (1992) Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb 12: 945–947PubMedCrossRefGoogle Scholar
  57. 57.
    Grayston JT, Kuo C-C, Campbell A, Beneditt EP (1993) Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 14: 66–71PubMedGoogle Scholar
  58. 58.
    Shor A, Kuo C-C, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82: 161–163Google Scholar
  59. 59.
    Kuo C-C, Shor A, Campbell LA et al (1993) Demonstration of Chlamydia pneumoniaein atherosclerotic lesions of coronary arteries. J Infect Dis 167: 841–849PubMedCrossRefGoogle Scholar
  60. 60.
    Campbell LA, O’Brien ER, Cappuccio AL et al (1995) Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172: 585–588PubMedCrossRefGoogle Scholar
  61. 61.
    Kuo C-C, Grayston JT, Campbell LA et al (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci USA 92: 6911–6914PubMedCrossRefGoogle Scholar
  62. 62.
    Muhlestein JB, Hammond EH, Carlquist JF et al (1996) Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 27: 1555–1561PubMedCrossRefGoogle Scholar
  63. 63.
    Ramirez JA, Ahkee S, Summersgill JT et al (1996) Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125: 979–982PubMedGoogle Scholar
  64. 64.
    Maass M, Bartels C, Engel PM et al (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31: 827–832PubMedCrossRefGoogle Scholar
  65. 65.
    Kuo C-C, Gown AM, Benditt EP et al (1993) Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13: 1501–1504PubMedCrossRefGoogle Scholar
  66. 66.
    Juvonen J, Juvonen T, Laurila A et al (1997) Demonstration of Chlamydia pneumoniae in the walls of abdominal aorta aneurysms. J Vasc Surg 25: 499–505PubMedCrossRefGoogle Scholar
  67. 67.
    Grayston JT, Kuo C-C, Coulson AS et al (1995) Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92: 3397–3400PubMedGoogle Scholar
  68. 68.
    Chiu B, Viira E, Tucker W, Fong IW (1997) Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96: 2144–2148PubMedGoogle Scholar
  69. 69.
    Yamashita K, Ouchi K, Shirai M et al (1998) Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29: 773–778PubMedCrossRefGoogle Scholar
  70. 70.
    Jackson LA, Campbell LA, Kuo C-C et al (1997) Isolation of Chlamydia pneumoniae from a carotid endoarterectomy specimen. J Infect Dis 176: 292–295PubMedCrossRefGoogle Scholar
  71. 71.
    Boman J, Söderberg S, Forsberg J et al (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178: 274–277PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • F. Blasi
  • R. Cosentini
  • P. Tarsia

There are no affiliations available

Personalised recommendations